Acardiac twin pregnancy is a rare but serious complication of monochorionic twinning. This acardiac twin gestation complicated by reversible severe pulmonary hypertension and biventricular hypertrophic cardiomyopathy in the pump twin demonstrates the importance of antenatal treatment.
Acardiac twin pregnancy is a rare but serious complication of monochorionic twinning. The acardia phenomenon has an incidence of 1% among monochorionic twins or 1 in 35,000 pregnancies (1) . An acardiac twin is a severely malformed fetus that lacks most organs, particularly a heart, but maintains its growth during pregnancy due to its perfusion by the developmentally normal pump twin via a set of arterio-arterial and veno-venous placental anastomoses. The development of a typical pump twin is initially normal; however complications of rapid onset such as plethora, cardiac decompensation, hydrops and intrauterine fetal death usually ensue in the second trimester (2) . Without therapy, about 50%-70% of the pump twins die due to congestive heart failure, polyhydramnios and premature delivery (2, 3) . Two cases of acardiac twin gestation complicated by hypertrophic cardiomyopathy have been described in the literature so far (4, 5) . We present an acardiac twin gestation complicated by severe reversible pulmonary hypertension and biventricular hypertrophic cardiomyopathy in the pump twin .
Case Presentation
A 22-year-old, primigravida woman was referred to our hospital in her 28th week of gestation because of the ultrasonographic detection of an acardiac acephalic twin and an active pump fetus with normal anatomy and marked polyhydramnios. In the 32nd week of gestation, the mother was found to have premature rupture of membranes and a female infant with fetal distress and weighing 1,750 g, was delivered with cesarean section. 
Discussion
It is well established that the pump twin has to circulate more blood volume than in normal conditions in order to perfuse the acardiac twin and that the circulating blood is less oxygenated than normal. Obviously this double volume load constitutes extra work for the surviving heart, which results in dilatation and hypertrophy of the left ventricule and heart failure.
Little is known about the course of the normalization process of myocardial hypertophy, however (2). Szatmari et al (5) described a case with acardiac twin pregnancy: the surviving infant presented with short-term heart failure with persistent left ventricular hypertrophy. Chandra et al (4) described another case with biventricular concentric hypertrophy which resolved with propranolol therapy without sequelae by one year of age. It is suggested that biventricular concentric hypertrophy and PPHN was a result of hymodynamic stress and that resolution of the hypertrophy occurred when the stress of the acardiac fetus was removed after birth.
Our case is different in its development of biventricular concentric hypertrophy with severe PPHN, the resolution of the severe pulmonary hypertension in two weeks and the resolution of the biventricular concentric hypetrophy in six months.
PPHN may accompany many types of neonatal chronic intrauterine hypoxia, which may result in hypertrophy of the medial musculature of pulmonary arterioles. Most neonates with PPHN are older than 32 weeks of gestational age and have advanced development of the musculature of pulmonary arterial bed. It has been shown that the degree of the development is directly proportional with gestational age and is appreciable after 32 weeks of gestation (6) . Pulmonary hypertension secondary to elevation of left atrial pressure is common in patients with hypertrophic cardiomyopathy; however severe pulmonary hypertension reaching systemic values is unusual in these patients, especially in the absence of severe obstruction and severe mitral regurgitation (7) . In the present case, the infant was 32 weeks gestational age and the diagnosis of PPHN was established by echocardiography.
Survival of one of the "pump" fetus implies the necessity of early diagnosis for the detection of gestational pathology, possible intrauterine interventions and monitoring of the healthy twin. Fetoscopic laser coagulation of placental vascular anastomoses or the umbilical cord of the acardiac twin is an effective treatment of twin reversed arterial perfusion sequence, with a survival rate of 80%, and 67% of pregnancies with surviving pump twins going beyond 36 weeks' gestation without further complications (8) . Therapies, including conservative treatment and invasive procedures, like intrafetal alcohol chemosclerosis, are directed towards achieving optimal maintenance of pump twins based on clinical presentation (9) . Fetal ventricular hypertrophy could not be diagnosed in our patient during routine antenatal care. In the antenatal ultrasonographic examination, diagnosis of the ventricular hypertrophy could be of great help in predicting the fetal and neonatal status.
Our case demonstrates without antenatal treatment acardiac twin gestation complicated by reversible severe pulmonary hypertension and biventricular hypertrophic cardiomyopathy in the pump twin. Effective antenatal treatment could be with surviving pump twins going beyond 36 weeks' gestation without further complications. Therefore the pump twin should be meticulously searched for physical and echocardiographic findings in collaboration with a pediatric cardiologist.
